Inventor · disambiguated record
Michael David Saunders
Also filed as: SAUNDERS MICHAEL · SAUNDERS MICHAEL DAVID · SAUNDERS MICHAEL J S
9 granted patents·9 pending applications·36 citations·filing 2004–2025
86Inventor score
Files withTOLERO PHARMACEUTICALS INC6SUMITOMO DAINIPPON PHARMA ONCOLOGY INC3GLAXOSMITHKLINE IP NO 2 LTD2SUMITOMO PHARMA AMERICA INC2XU YONG2
Top patents by PatentIndex Score
18 records- 0195US9394257B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2013·Granted Jul 19, 2016·22 cites·52 claims
- 0284US10875864B2Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitorsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2019·Granted Dec 29, 2020·1 cites·28 claims
- 0384US10047093B2Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitorsTOLERO PHARMACEUTICALS INC·Filed 2016·Granted Aug 14, 2018·3 cites·42 claims
- 0484US2025129085A1Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 0583US10392392B2Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitorsTOLERO PHARMACEUTICALS INC·Filed 2018·Granted Aug 27, 2019·2 cites·35 claims
- 0682US10766865B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·1 cites·17 claims
- 0782US10472328B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2018·Granted Nov 12, 2019·2 cites·20 claims
- 0881US9416132B2Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsXU YONG·Filed 2012·Granted Aug 16, 2016·3 cites·16 claims
- 0979US10207996B2PKM2 modulators and methods for their useTOLERO PHARMACEUTICALS INC·Filed 2016·Granted Feb 19, 2019·2 cites·37 claims
- 1072US2021238183A1Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1171US2025320217A1Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitorsSUMITOMO PHARMA AMERICA INC·Filed 2025·Application pending·0 cites
- 1271US2021002233A1Pkm2 modulators and methods for their useSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1353US2009275583A1Antiviral compounds and use thereofMYRIAD GENETICS INC·Filed 2009·Application pending·0 cites
- 1443US2014357594A1New compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2012·Application pending·0 cites
- 1538US9174984B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2012·Granted Nov 3, 2015·0 cites·19 claims
- 1638US2012058997A1Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitorsXU YONG·Filed 2011·Application pending·0 cites
- 1734US2012122840A1Compounds and therapeutic uses thereofKUMAR DANGE VIJAY·Filed 2011·Application pending·0 cites
- 1833US2007092910A1Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseasesDEVGEN NV·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael David Saunders files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →